Tailored therapeutic strategies for synovial sarcoma: Receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001-Reference-Cited by-同舟云学术

Tailored therapeutic strategies for synovial sarcoma: Receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001

Published:2014-05 Issue:1 Volume:347 Page:114-122
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Yasui Hirohiko,Naka Norifumi,Imura Yoshinori,Outani Hidetatsu,Kaneko Keiko,Hamada Ken-ichiro,Sasagawa Satoru,Araki Nobuhito,Ueda Takafumi,Itoh Kazuyuki,Myoui Akira,Yoshikawa Hideki

Funder

the Japan Society for the Promotion of Science, JSPS KAKENHI

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Enzinger and Weiss’s Soft Tissue Tumors;Weiss,2008

2. Synovial sarcoma is a stem cell malignancy;Naka;Stem Cells,2010

3. Pathology of soft tissue sarcomas;Thway;Clin. Oncol.,2009

4. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity;Lewis;J. Clin. Oncol.,2000

5. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors;Krieg;Ann. Oncol.,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes;Current Oncology Reports;2020-10-06

2. MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction;Neoplasia;2020-08

3. The Role of Shcbp1 in Signaling and Disease;Current Cancer Drug Targets;2019-12-23

4. Advances in the treatment of soft tissue sarcoma: focus on eribulin;Cancer Management and Research;2018-02

5. Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications;Cancer Treatment Reviews;2018-02